menu
    • menu

    Company profile for Handa Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche drug. The company’s overall business strategy comprises of utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China) through US subsidiaries and Hangzhou Handa Pharmaceutical Technology Co., Ltd., respectively. Handa Pharm...
    Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche drug. The company’s overall business strategy comprises of utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China) through US subsidiaries and Hangzhou Handa Pharmaceutical Technology Co., Ltd., respectively. Handa Pharma integrates its own pharmaceutical development platform with patent analysis, medicine and pharmaceuticals regulatory, and market planning to focus on the development of high barrier/patentable niche.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Handa PharmaceuticalsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    3F-1&3F-2, No.23, Nanke 3rd Rd., Tainan City 74147, Taiwan (R.O.C.)
    Telephone
    Telephone
    +886-6-5057508
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://handapharma.com.tw/zh/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xspray Inks Licensing Deal with Handa Therapeutics for Royalties
    Xspray Inks Licensing Deal with Handa Therapeutics for Royalties

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812575897/en/Xspray-Pharma-Signs-License-Agreement-with-Handa-Therapeutics-to-Receive-up-to-Double-Digit-Royalty-on-Handas-Net-Proceeds

    BUSINESSWIRE
    12 Aug 2025
    Share Share
    Cycle Pharmaceuticals Inks U.S. License Deal for Phrago Tablets
    Cycle Pharmaceuticals Inks U.S. License Deal for Phrago Tablets

    21 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250718163510/en/Cycle-Pharmaceuticals-Signs-Exclusive-U.S.-Sales-License-for-PHYRAGO-dasatinib-Tablets

    BUSINESSWIRE
    21 Jul 2025
    Share Share
    Handa Pharma`s Generics Varenicline Receives Approval in US
    Handa Pharma`s Generics Varenicline Receives Approval in US

    21 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213268

    FDA
    21 May 2025
    Share Share
    Handa Acquires FDA Approved Leukemia Drug, Phyrago Tablets
    Handa Acquires FDA Approved Leukemia Drug, Phyrago Tablets

    16 Jan 2025

    // ACCESSWIRE

    https://www.accesswire.com/968656/handa-therapeutics-acquires-fda-approved-chronic-myeloid-leukemia-drug-phyrago-dasatinib-tablets

    ACCESSWIRE
    16 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search